Robert Sutphin is an Oncology physician affiliated with Orlando Health. OpenAlex indexes 22 publications with 445 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combination of 13 cis‐retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high‐risk neuroblastoma cell proliferation
International Journal of Developmental Neuroscience
2015 - Abstract A02: Chemo-sensitization of medulloblastoma cells using small molecule tolfenamic acid
Clinical Cancer Research
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Eleftherios Mamounas, MD
Orlando Health
Manoel Dos Passos Galvao Neto, MD
Orlando Health
Karoly Horvath, MD
Orlando Health
Mohamed Elshazly, MD
Orlando Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”